Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shibuya

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|August 5, 2003
Development and functions of natural killer cellsAkira Shibuya
Biomedical Journal|April 11, 2021
Type 1 innate lymphoid cells: Soldiers at the front line of immunityTsukasa Nabekura, Akira Shibuya
Immunity|February 10, 2021
ILC1: guardians of the oral mucosa against enemy virusesTsukasa Nabekura, Akira Shibuya
International Immunology|October 25, 2021
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responsesAkira Shibuya, Kazuko Shibuya
Cell Host & Microbe|December 14, 2018
Exploring the Gut Fungi-Lung Allergy AxisAkira Shibuya, Kazuko Shibuya
Immunological Reviews|October 27, 2015
Immune regulation by Fcα/μ receptor (CD351) on marginal zone B cells and follicular dendritic cellsAkira Shibuya, Shin-ichiro Honda
Springer Seminars in Immunopathology|October 25, 2006
Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgAAkira Shibuya, Shin-Ichiro Honda
Advances in Therapy|February 20, 2026
Safety and Tolerability of Nintedanib in Japanese Patients with Progressive Fibrosing Interstitial Lung Diseases: Final Results of 2-Year Post-Marketing SurveillanceTomohiro Ito, Akira Shibuya, Hiroko Noguchi
International Immunology|February 3, 2005
Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226)Jun Shirakawa, Kazuko Shibuya, Akira Shibuya
Current Protocols|August 10, 2024
Concanavalin-A-Induced Acute Liver Injury in MiceTsukasa Nabekura, Soichi Matsuo, Akira Shibuya
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|August 5, 2003
Development and functions of natural killer cellsAkira Shibuya
Biomedical Journal|April 11, 2021
Type 1 innate lymphoid cells: Soldiers at the front line of immunityTsukasa Nabekura, Akira Shibuya
Immunity|February 10, 2021
ILC1: guardians of the oral mucosa against enemy virusesTsukasa Nabekura, Akira Shibuya
International Immunology|October 25, 2021
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responsesAkira Shibuya, Kazuko Shibuya
Cell Host & Microbe|December 14, 2018
Exploring the Gut Fungi-Lung Allergy AxisAkira Shibuya, Kazuko Shibuya
Immunological Reviews|October 27, 2015
Immune regulation by Fcα/μ receptor (CD351) on marginal zone B cells and follicular dendritic cellsAkira Shibuya, Shin-ichiro Honda
Springer Seminars in Immunopathology|October 25, 2006
Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgAAkira Shibuya, Shin-Ichiro Honda
Advances in Therapy|February 20, 2026
Safety and Tolerability of Nintedanib in Japanese Patients with Progressive Fibrosing Interstitial Lung Diseases: Final Results of 2-Year Post-Marketing SurveillanceTomohiro Ito, Akira Shibuya, Hiroko Noguchi
International Immunology|February 3, 2005
Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226)Jun Shirakawa, Kazuko Shibuya, Akira Shibuya
Current Protocols|August 10, 2024
Concanavalin-A-Induced Acute Liver Injury in MiceTsukasa Nabekura, Soichi Matsuo, Akira Shibuya
Pageof 15